Keynote Speaker

Yves Brun

Yves Brun is a Distinguished Professor and the Canada 150 Research Chair in Bacterial Cellular Biology at the Université de Montréal in the Département de microbiologie, infectiologie et immunologie. Prior to moving his lab to Montréal in 2019, Dr. Brun was the Clyde Culbertson and Distinguished Professor of Biology at Indiana University and continues this 26-year association as a Distinguished Professor Emeritus.

 

P1 Research

 

P2 Awards

Dr. Brun received his B.Sc. and M.Sc. from Université de Moncton where he performed research on the mechanisms of protein synthesis funded by fellowships from the Science and Engineering Research Council of Canada (NSERC), and for which he received the Governor General of Canada Gold Medal for graduate work. He obtained his Ph.D. in Biochemistry from Université Laval for work on the evolution and regulation of tRNA and aminoacyl tRNA synthetase genes with fellowship support from NSERC. He conducted postdoctoral research at Stanford University, where I performed research on the regulation of bacterial cell differentiation with Lucy Shapiro, funded by fellowships from NSERC and the Medical Research Council of Canada. I moved to a faculty position at Indiana University.

 

 

He is an elected fellow of the American Academy of Microbiology (2010), the American Association for the Advancement of Science (2012), the Canadian Academy of Health Sciences (2020), and the Royal Society of Canada (2021).

 

P3 Commitment to students/trainees

During his tenure at Indiana University, he served as the Director of the Microbiology Graduate Program and Associate Chair for Microbiology

 

 

Since the beginning of her tenure at the Mayo Clinic, Dr. Patel has focused her research on multiple critical components of bacteriological infections in clinical settings. Her work primarily focuses on three major areas: (1) improvement of next-generation diagnostics techniques, (2) understanding the inherent biology of periprosthetic biofilm formation, and (3) understanding antibiotic resistance within the clinic. She has published over 500 peer-reviewed publication and is well supported by the National Institutes of Health. Since the start of the SARS-COV-2 pandemic, Dr. Patel has used her expertise in diagnostics to be a prominent voice in scientific communication with the public.

 

To say Dr. Patel’s pedigree is impressive would be an understatement. She received her BA in Chemistry from Princeton University, where she graduated magna cum laude with nomination to Sigma Xi. From there, she obtained her MD from McGill. Afterwards, Dr. Patel completed her internal medicine residency at the Mayo Clinic before completing fellowships in Clinical Microbiology and Infectious Disease where she secured awards from both the Mayo Clinic and the American Society for Microbiology. Since then, she has been significantly involved in setting the standards for diagnostic and clinical care of bacterial infections in the United States, as evidenced by the positions she has held or holds within the American Society for Microbiology (President), American Board of Pathology (Microbiology Test Writing Committee Member), Clinical and Laboratory Standards Institute (Subcommittee on Antimicrobial Susceptibility Testing Voting Member), National Institutes of Allergy and Infectious Diseases (Council Member), National Board of Medical Examiners (Microbiology/Immunology Test Material Development Committee Member and Chair), Journal of Clinical Microbiology (Associate Editor), and Clinical Infectious Diseases (Associate Editor).

 

In addition, Dr. Patel’s continued commitment to mentorship can be translated into a long list of students from around the world; she had dedicated hours of teaching to train the next generation of scientists and MDs.

 

This profile information was adapted from: https://journals.asm.org/doi/10.1128/JCM.01259-20.